Literature DB >> 32547684

How old is too old? In vivo engraftment of human peripheral blood stem cells cryopreserved for up to 18 years - implications for clinical transplantation and stability programs.

John Underwood1, Mahvish Rahim2, Carijo West3, Rebecca Britton3, Elaine Skipworth3, Vicki Graves3, Steven Sexton3, Hillary Harris3, Dave Schwering3, Anthony Sinn4, Karen E Pollok2, Kent A Robertson2, W Scott Goebel5, Kerry M Hege2.   

Abstract

BACKGROUND: Peripheral blood stem cells (PBSC) are commonly cryopreserved awaiting clinical use for hematopoietic stem cell transplant. Long term cryopreservation is commonly defined as five years or longer, and limited data exists regarding how long PBSC can be cryopreserved and retain the ability to successfully engraft. Clinical programs, stem cell banks, and regulatory and accrediting agencies interested in product stability would benefit from such data. Thus, we assessed recovery and colony forming ability of PBSC following long-term cryopreservation as well as their ability to engraft in NOD/SCID/IL-2Rγnull (NSG) mice. AIM: To investigate the in vivo engraftment potential of long-term cryopreserved PBSC units.
METHODS: PBSC units which were collected and frozen using validated clinical protocols were obtained for research use from the Cellular Therapy Laboratory at Indiana University Health. These units were thawed in the Cellular Therapy Laboratory using clinical standards of practice, and the pre-freeze and post-thaw characteristics of the units were compared. Progenitor function was assessed using standard colony-forming assays. CD34-selected cells were transplanted into immunodeficient mice to assess stem cell function.
RESULTS: Ten PBSC units with mean of 17 years in cryopreservation (range 13.6-18.3 years) demonstrated a mean total cell recovery of 88% ± 12% (range 68%-110%) and post-thaw viability of 69% ± 17% (range 34%-86%). BFU-E growth was shown in 9 of 10 units and CFU-GM growth in 7 of 10 units post-thaw. Immunodeficient mice were transplanted with CD34-selected cells from four randomly chosen PBSC units. All mice demonstrated long-term engraftment at 12 wk with mean 34% ± 24% human CD45+ cells, and differentiation with presence of human CD19+, CD3+ and CD33+ cells. Harvested bone marrow from all mice demonstrated growth of erythroid and myeloid colonies.
CONCLUSION: We demonstrated engraftment of clinically-collected and thawed PBSC following cryopreservation up to 18 years in NSG mice, signifying likely successful clinical transplantation of PBSC following long-term cryopreservation. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Colony-forming units assay; Cryopreservation; Hematopoietic stem cell transplantation; Hematopoietic stem cells; In vitro techniques; Long-term storage; Peripheral blood stem cell; Transplant; Viability

Year:  2020        PMID: 32547684      PMCID: PMC7280863          DOI: 10.4252/wjsc.v12.i5.359

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  29 in total

1.  Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage.

Authors:  Elisabeth E Spurr; Nicole E Wiggins; Katherine A Marsden; Raymond M Lowenthal; Scott J Ragg
Journal:  Cryobiology       Date:  2002-06       Impact factor: 2.487

2.  Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.

Authors:  Hal E Broxmeyer; Man-Ryul Lee; Giao Hangoc; Scott Cooper; Nutan Prasain; Young-June Kim; Coleen Mallett; Zhaohui Ye; Scott Witting; Kenneth Cornetta; Linzhao Cheng; Mervin C Yoder
Journal:  Blood       Date:  2011-03-10       Impact factor: 22.113

3.  Long-term cryopreservation of bone marrow for autologous transplantation.

Authors:  H Attarian; Z Feng; C D Buckner; B MacLeod; S D Rowley
Journal:  Bone Marrow Transplant       Date:  1996-03       Impact factor: 5.483

4.  Impact of long-term cryopreservation on single umbilical cord blood transplantation outcomes.

Authors:  Richard Mitchell; John E Wagner; Claudio G Brunstein; Qing Cao; David H McKenna; Troy C Lund; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-28       Impact factor: 5.742

5.  Humanized bone marrow mouse model as a preclinical tool to assess therapy-mediated hematotoxicity.

Authors:  Shanbao Cai; Haiyan Wang; Barbara Bailey; Aaron Ernstberger; Beth E Juliar; Anthony L Sinn; Rebecca J Chan; David R Jones; Lindsey D Mayo; Arthur R Baluyut; W Scott Goebel; Karen E Pollok
Journal:  Clin Cancer Res       Date:  2011-04-12       Impact factor: 12.531

6.  High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years.

Authors:  Hal E Broxmeyer; Edward F Srour; Giao Hangoc; Scott Cooper; Stacie A Anderson; David M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-07       Impact factor: 11.205

7.  Long-term storage of peripheral blood stem cells frozen and stored with a conventional liquid nitrogen technique compared with cells frozen and stored in a mechanical freezer.

Authors:  Jeffrey McCullough; Rebecca Haley; Mary Clay; Allison Hubel; Bruce Lindgren; Gary Moroff
Journal:  Transfusion       Date:  2009-11-13       Impact factor: 3.157

8.  Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservation.

Authors:  J Pavlů; H W Auner; R M Szydlo; B Sevillano; R Palani; F O'Boyle; A Chaidos; C Jakob; E Kanfer; D MacDonald; D Milojkovic; A Rahemtulla; A Bradshaw; E Olavarria; J F Apperley; O M Pello
Journal:  Bone Marrow Transplant       Date:  2017-06-26       Impact factor: 5.483

9.  Long-Term Outcome after Autologous Stem Cell Transplantation with Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphoma and Myeloma Patients.

Authors:  Jan S Moreb; Donya Salmasinia; Jack Hsu; Wei Hou; Christina Cline; Emma Rosenau
Journal:  Adv Hematol       Date:  2011-11-29

10.  Differential Secondary Reconstitution of In Vivo-Selected Human SCID-Repopulating Cells in NOD/SCID versus NOD/SCID/γ chain Mice.

Authors:  Shanbao Cai; Haiyan Wang; Barbara Bailey; Jennifer R Hartwell; Jayne M Silver; Beth E Juliar; Anthony L Sinn; Arthur R Baluyut; Karen E Pollok
Journal:  Bone Marrow Res       Date:  2010-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.